Market Place
Sourcing Support
Duet BioTherapeutics Presents Data for a Novel Treatment for Malignant Glioma
07 Nov 2023 //
GLOBENEWSWIRE
Scopus Bio™s Subsidiary ” Duet BioTherapeutics ” to Present at Annual Meeting
02 Nov 2023 //
GLOBENEWSWIRE
Scopus BioPharma’s Subsidiary Duet BioThera Announces Scientific Data at (SITC)
10 Nov 2022 //
GLOBENEWSWIRE
Scopus Completes Recapitalization Designed To Enhance Shareholder Value
18 Oct 2022 //
GLOBENEWSWIRE
Scopus Bio Announces Biotechnology Industry Leader Rejoins Board of Directors
05 May 2022 //
GLOBENEWSWIRE
Duet BioTherapeutics to Present at 3rd STING & TLR-Targeting Therapies Summit
22 Mar 2022 //
GLOBENEWSWIRE
Scopus BioPharma Provides Update Following Annual Meeting of Stockholders
10 Jan 2022 //
GLOBENEWSWIRE
Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris
17 Dec 2021 //
GLOBENEWSWIRE
Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL”
07 Dec 2021 //
GLOBENEWSWIRE
Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders
08 Oct 2021 //
GLOBENEWSWIRE
Scopus BioPharma Retaining Counsel to Investigate Unusual Market Activity
01 Oct 2021 //
GLOBENEWSWIRE
Scopus BioPharma`s Subsidiary — Duet — Announces Release of Preclinical Data
29 Sep 2021 //
GLOBENEWSWIRE
Scopus BioPharma’s Subsidiary — Duet — Set to Release Scientific Data
28 Sep 2021 //
GLOBENEWSWIRE
Scopus BioPharma to Present at the Benzinga Healthcare Small Cap Conference
23 Sep 2021 //
GLOBENEWSWIRE
Scopus BioPharma`s Subsidiary to Present at the 17th Annual Meeting
22 Sep 2021 //
GLOBENEWSWIRE
Duet Therapeutics Appoints Marcin Kortylewski as Senior Scientific Advisor
07 Sep 2021 //
GLOBENEWSWIRE
Scopus BioPharma Launches Duet Therapeutics
02 Sep 2021 //
GLOBENEWSWIRE
Scopus BioPharma Announces New Management Appointment
12 Jul 2021 //
GLOBENEWSWIRE
Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune
01 Jul 2021 //
BIOSPACE
Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune
01 Jul 2021 //
BIOSPACE
Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune
30 Jun 2021 //
GLOBENEWSWIRE
Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune
30 Jun 2021 //
BIOSPACE
Scopus BioPharma Announces FDA Approval of IND Application for Lead Drug
24 May 2021 //
GLOBENEWSWIRE
Scopus BioPharma Announces IND Submission to FDA for Lead Drug Candidate
26 Apr 2021 //
PRNEWSWIRE
Scopus BioPharma Finalizes Arrangements for Submission of IND Package
15 Mar 2021 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.